Serum‐free suspension cultured human cells can produce a high‐level of recombinant human erythropoietin
Open Access
- 5 May 2020
- journal article
- research article
- Published by Wiley in Engineering Reports
- Vol. 2 (6)
Abstract
Currently, the majority of commercial recombinant therapeutic proteins are produced in nonhuman expression systems. Human cells are capable of producing recombinant proteins with post‐translational modifications that are more similar to native proteins which reduce immunogenicity. This article describes the potential of the human cell lines Sk‐Hep‐1, HKB‐11, and Huh‐7, cultured in serum‐free suspension conditions, to produce a complex recombinant glycoprotein, human erythropoietin (EPO). Recombinant cell lines were generated by lentiviral transduction and sorted by flow cytometry. All the recombinant cells presented high‐specific cell growth rates and a high level of rhEPO production. Maximum rhEPO concentrations achieved by Sk‐Hep‐1, HKB‐11, and Huh‐7 cells were 112.5 μg/mL, 112.7 μg/mL, and 571 μg/mL, respectively. The levels of rhEPO production by Huh‐7 cells were higher than the levels commonly reported in the literature for serum‐free suspension cultures. The rhEPO produced demonstrated biological activity measured through in vitro differentiation of CD34+ cells. In view of this, we demonstrate that Sk‐Hep‐1, HKB‐11, and Huh‐7 cell lines have good characteristics to be used as host cells for the production of complex recombinant glycoproteins, with special emphasis on Huh‐7 due to enhanced EPO production.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (573754‐2008‐0)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (1544865)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2008/578773, 2012/04629‐8, 2013/08135‐2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 69 references indexed in Scilit:
- Rapid Generation of Stable Cell Lines Expressing High Levels of Erythropoietin, Factor VIII, and an Antihuman CD20 Antibody Using Lentiviral VectorsHuman Gene Therapy Methods, 2013
- SK-HEP cells and lentiviral vector for production of human recombinant factor VIIIBiotechnology Letters, 2012
- Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysisBioprocess and Biosystems Engineering, 2010
- Influence of different ammonium, lactate and glutamine concentrations on CCO cell growthCytotechnology, 2010
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteinsNature Biotechnology, 2010
- Uniquely human evolution of sialic acid genetics and biologyProceedings of the National Academy of Sciences, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cellsBMC Biotechnology, 2008
- Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selectionBMC Biotechnology, 2008
- Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cellsBiotechnology and Bioengineering, 2003